Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Nycomed suspends development of anticlotting agent

Nov. 8, 1996

Cor Therapeutics' fibrinogen receptor antagonist effective in unstable angina

Nov. 8, 1996

Orally active antithrombotic RGD-mimetics reported by E. Merck

Nov. 8, 1996

Fujisawa claims fibrinogen antagonists

Nov. 8, 1996

Canadian researchers claim hirudin derivative

Nov. 8, 1996

Factor Xa/thrombin inhibitors from Roche

Nov. 1, 1996

Berlex discloses factor Xa inhibitors

Nov. 1, 1996

Transgenic ATIII proven safe in healthy volunteers

Oct. 25, 1996

Promising preliminary phase II results for argatroban in acute MI

Oct. 25, 1996

Servier selects TxA2 antagonist for further study

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...